Diana Hristova | Clinical Medicine | Best Medical Scientist Award

Published on by Health Scientists

Best Medical Scientist Award

Diana Hristova
Aleksandrovska University Hospital
Diana Hristova
Affiliation Aleksandrovska University Hospital
Country Bulgaria
Scopus ID 57450761900
Documents 12
Citations 55
h-index 3
Subject Area Clinical Medicine
Event Health Scientists Awards
ORCID 0000-0002-9710-1312

The Best Medical Scientist Award recognizes researchers whose scholarly activities contribute to the advancement of medical science and patient-centered healthcare. Diana Hristova of Aleksandrovska University Hospital has developed a research profile within clinical medicine, contributing peer-reviewed publications and scholarly outputs that support evidence-based healthcare practices. Her academic activities, publication record, and participation in contemporary medical research demonstrate continued engagement with clinical investigation and scientific dissemination.[1]

Abstract

Diana Hristova is a clinical medicine researcher affiliated with Aleksandrovska University Hospital in Bulgaria. Her scholarly work focuses on medical research, patient care improvement, and evidence-based clinical practice. Through peer-reviewed publications and scientific collaboration, she has contributed to the understanding of healthcare challenges and clinical outcomes. Her research activities support the translation of scientific knowledge into practical healthcare applications. With documented publications, citations, and academic engagement, her profile reflects sustained participation in the advancement of medical science and clinical investigation while contributing to ongoing developments within contemporary healthcare research environments.[1]

Keywords

Clinical Medicine, Healthcare Research, Evidence-Based Medicine, Medical Science, Patient Care, Clinical Investigation, Medical Publications, Translational Research, Hospital Research, Health Outcomes

Introduction

Clinical medicine relies on rigorous research to improve patient outcomes and healthcare quality. Diana Hristova contributes to this objective through scholarly activities at Aleksandrovska University Hospital. Her research engagement supports scientific inquiry, knowledge dissemination, and evidence-based approaches that strengthen contemporary medical practice and healthcare decision-making processes.[1]

Research Profile

Diana Hristova maintains an active research profile within clinical medicine, supported by indexed publications and measurable scholarly impact. Her academic record demonstrates participation in peer-reviewed research, scientific communication, and collaborative medical investigations that contribute to the broader understanding of clinical challenges and healthcare improvement initiatives.[1]

Research Contributions

Her contributions involve clinical research activities that support evidence generation, patient-centered healthcare, and medical knowledge development. Through published studies and professional collaboration, she has participated in advancing scientific understanding relevant to healthcare practice, clinical assessment, and improved treatment strategies within medical environments.[2]

Publications

The researcher has authored and co-authored multiple scholarly publications indexed within recognized academic databases. These publications contribute to clinical medicine literature and reflect ongoing engagement with scientific research, peer review standards, and the dissemination of findings relevant to healthcare professionals and researchers.[1]

Research Impact

Research impact is reflected through citations, publication visibility, and academic engagement. Diana Hristova’s scholarly outputs contribute to knowledge exchange within clinical medicine. Her research record demonstrates recognized academic influence and supports the continued development of evidence-based healthcare practices across relevant medical disciplines.[1]

Award Suitability

The Best Medical Scientist Award emphasizes scientific contribution, research quality, and healthcare relevance. Diana Hristova’s publication record, documented citations, clinical research involvement, and commitment to evidence-based medicine align with these evaluation principles, making her profile suitable for consideration within medical science recognition programs.[1]

Conclusion

Diana Hristova demonstrates a sustained commitment to clinical medicine research through scholarly publication, academic collaboration, and healthcare-focused investigation. Her research profile reflects meaningful participation in scientific advancement and supports the objectives of medical innovation, evidence generation, and improved patient care outcomes.[2]

References

  1. Elsevier. (n.d.). Scopus author details: Diana Hristova, Author ID 57450761900. Scopus.

    https://www.scopus.com/authid/detail.uri?authorId=57450761900
  2. ORCID. (n.d.). Diana Hristova Research Profile.

    https://orcid.org/0000-0002-9710-1312

Zelimkhan Berikkhanov | Clinical Medicine | Young Researcher Award

Published on by Health Scientists

Mr. Zelimkhan Berikkhanov | Clinical Medicine | Young Researcher Award

Assistant Professor | I.M. Sechenov First Moscow State Medical University | Russia

Dr. Zelimkhan Berikkhanov is a clinician-scientist whose work spans thoracic surgery, pulmonology, infectious diseases, oncology, and public health, with a strong emphasis on developing evidence-based approaches to complex respiratory and surgical disorders. His professional career integrates academic leadership as an assistant professor and methodologist with active clinical responsibilities at the National Medical Research Center for Pulmonology and Sechenov University, where he contributes to advanced surgical care, methodological development, and multidisciplinary education. His research portfolio reflects a diverse and impactful scholarly trajectory, encompassing peer-reviewed studies on tracheal reconstruction, thoracic oncology, diaphragmatic trauma, critical respiratory conditions, chronic obstructive pulmonary disease, COVID-associated pneumonia, nanomaterials in gastrointestinal pathology, digital tools in chronic disease management, and telemedicine in pulmonology. He has collaborated extensively with leading national and international experts, contributing to multi-center investigations, clinical guidelines, and translational research aimed at improving diagnostic accuracy, postoperative outcomes, and respiratory care pathways. His scientific productivity is demonstrated through a broad range of publications across high-quality journals, addressing both fundamental mechanisms and applied clinical innovations. His work on COVID-19 significantly advanced understanding of silent hypoxemia, cavitary lung disease, vibroacoustic therapy, and pharmacologic strategies, while his contributions to thoracic surgery strengthened evidence on complex tracheal and bronchial interventions. His participation in research on artificial intelligence for mortality prediction, biomarkers for pulmonary hypertension, metabolic instability in malignancies, and advanced imaging of the lymphatic system underscores his commitment to cross-disciplinary innovation. Through active collaboration, methodological leadership, and involvement in forward-looking clinical studies, Dr. Berikkhanov has helped shape modern approaches to respiratory medicine and thoracic surgery, generating insights that support better patient outcomes and inform national strategies in pulmonary care. His work continues to influence clinical practice, strengthen scientific networks, and enhance healthcare delivery through integrated, technology-supported, and patient-centered frameworks. He has 62 citations from 27 documents with an h-index of 4.

Profiles:  Scopus | ORCID

Featured Publications

1. Sukhanova, M. A., Muraviev, S. Y., Tarabrin, E. A., Shestakov, A. L., Berikkhanov, Z. G. M., Tarasova, I. A., Razumovsky, V. S., Markov, I. A., & Fabrika, A. P. (2025). The role of “metabolic instability” as a new risk criterion in the pathogenesis of endometrial cancer. Cancers.

2. Nagatkina, O. V., Proshkina, A. A., Makarova, N. M., Sokolova, E. S., Merzhoeva, Z. M., Nikitina, L. Y., Nuralieva, G. S., Berikchanov, Z. G., Ainetdinov, R. M., & Avdeev, S. N. (2025). Digital technologies for outpatient management of patients with chronic obstructive pulmonary disease: Opportunities to reduce the burden of the disease. Russian Journal of Preventive Medicine.

3. Ma, T., Berikkhanov, Z. G., Timashev, P. S., Khristidis, Y. I., Ivanova, M. Y., Ershov, B. P., Liu, T., & Tarabrin, E. A. (2025). A comparative study to evaluate the efficacy of sealants alone and in combination with collagen sheet in a pig isolated lung air leak model. Russian Journal of Operative Surgery and Clinical Anatomy.

4. Razumovsky, V. S., Tarabrin, E. A., Muravyov, S. Y., Berikkhanov, Z. G. M., & Konosevich, D. O. (2025). Diagnostics and visualization of the lymphatic system in clinical practice. Russian Sklifosovsky Journal “Emergency Medical Care.

5. Avdeev, S. N., Gaynitdinova, V. V., Merzhoeva, Z. M., Nuralieva, G. S., Tarabrin, E. A., Berikkhanov, Z. G., Nikitina, L. Y., Gneusheva, T. Y., Sokolova, E. S., Ainetdinov, R. M., et al. (2025). NT-proCNP as a new biomarker of pulmonary hypertension in patients with COPD. Scientific Reports.

Yang Zhang | Clinical Medicine | Best Researcher Award

Published on by Health Scientists

Prof. Dr. Yang Zhang | Clinical Medicine | Best Researcher Award 

Director | Department of Laboratory Medicine Chongqing University | China

Dr. Yang Zhang, Ph.D., currently serves as Director of the Department of Laboratory Medicine at Chongqing University Affiliated Renji Hospital and is an Associate Chief Physician, Postdoctoral Fellow in Clinical Laboratory Diagnostics, and doctoral and master’s supervisor at Chongqing University. She earned her Bachelor of Medicine in Laboratory Medicine (2008), Master of Medicine in Clinical Laboratory Diagnostics (2011), and Ph.D. in Clinical Laboratory Diagnostics (2015) from the Third Military Medical University, complemented by a Ministry of Education-sponsored visiting scholarship at Loma Linda University, USA (2012–2015). Her research centers on precision molecular diagnostics in oncology, with a special focus on POCT rapid diagnostic reagents and spectroscopy-based label-free diagnostic techniques. Dr. Zhang has led multiple high-level research projects, including three funded by the National Natural Science Foundation of China, one by the National Key R&D Program, and numerous provincial and military projects, securing over 6.88 million RMB in funding. She has published more than 40 academic papers as first or corresponding author, with 15 SCI-indexed articles, an H-index of 24, and a single paper cited over 280 times. Her scholarly contributions extend to 12 Chinese invention patents, 1 international PCT patent, and five co-edited scientific monographs, including works on molecular diagnostics and terahertz applications. Dr. Zhang’s achievements have been recognized with numerous honors, such as Chongqing High-Level Young Medical Talent (2022), the “Top Ten Young Scientists in Shapingba District” (2022), First Prize in the Chongqing Association for Science and Technology Innovation (2023), and the National Laboratory Medicine Science and Technology Innovation Award (2021). She also serves as a reviewer for the NSFC and contributes to several national professional committees in laboratory medicine. She has 1044 citations from 43 documents with an h-index of 16.

Profile: Scopus | ORCID 

Publications

1. Zhang, Y. (2020). ENT1 inhibition attenuates apoptosis by activation of cAMP/pCREB/Bcl2 pathway after MCAO in rats. Experimental Neurology, 331, 113362.

2. Zhang, Y. (2020). Identification of immune-related prognostic biomarkers based on the tumor microenvironment in 20 malignant tumor types with poor prognosis. Frontiers in Oncology, 10, 1008.

3. Tian, H., Yuan, C., Liu, Y., Xia, K., Li, M., Xie, F., Chen, Q., Chen, M., Fu, W., & Zhang, Y. (2020, July 28). A sample-to-answer quantification platform for point-of-care testing of circulating microRNAs based on allosteric spherical nanoprobe. Preprint.

4. Zhang, Y. (2020). Evaluation of the reliability of six commercial SERS substrates. Plasmonics, 15(5), 1323–1332.

5. Zhang, Y. (2020). Dataset concerning plasmonic thermal destruction of murine melanoma by gold nanoparticles obtained by green chemistry. Data in Brief, 30, 105370.